We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPN icon
1326
Appian
APPN
$1.74B
-84,841
Closed -$2.92M
APVO icon
1327
Aptevo Therapeutics
APVO
$5.47M
0
-$33K
AQN icon
1328
Algonquin Power & Utilities
AQN
$4.69B
-75,564
Closed -$851K
ARES icon
1329
Ares Management
ARES
$28.5B
-6,269
Closed -$145K
ARGX icon
1330
argenx
ARGX
$57.4B
-973
Closed -$121K
ARI
1331
Apollo Commercial Real Estate
ARI
$887M
-54,348
Closed -$989K
ARLO icon
1332
Arlo Technologies
ARLO
$1.4B
-17,835
Closed -$74K
ARR
1333
Armour Residential REIT
ARR
$2.02B
-68,945
Closed -$6.73M
ASHR icon
1334
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
-120,000
Closed -$3.14M
ASML icon
1335
ASML
ASML
$675B
-258
Closed -$49K
ASND icon
1336
Ascendis Pharma A/S
ASND
$16.7B
-28,948
Closed -$3.41M
ATEX icon
1337
Anterix
ATEX
$1.83B
-12,171
Closed -$428K
ATO icon
1338
Atmos Energy
ATO
$29.9B
-37,912
Closed -$3.9M
ATR icon
1339
AptarGroup
ATR
$8.45B
-18,691
Closed -$1.99M
ATRA icon
1340
Atara Biotherapeutics
ATRA
$71.2M
-286
Closed -$284K
AU icon
1341
AngloGold Ashanti
AU
$40.3B
-85,532
Closed -$1.12M
AUB icon
1342
Atlantic Union Bankshares
AUB
$5.99B
-4,458
Closed -$144K
AVA icon
1343
Avista
AVA
$3.47B
-884
Closed -$36K
AVAL icon
1344
Grupo Aval
AVAL
$5.67B
-50,364
Closed -$392K
AWI icon
1345
Armstrong World Industries
AWI
$6.86B
-201,494
Closed -$16M
AXDX
1346
DELISTED
Accelerate Diagnostics
AXDX
-1,514
Closed -$318K
AXS icon
1347
AXIS Capital
AXS
$8.59B
-3,145
Closed -$172K
AZZ icon
1348
AZZ Inc
AZZ
$4.5B
-40,288
Closed -$1.65M
AZO icon
1349
AutoZone
AZO
$48.3B
-5,011
Closed -$5.13M
BALL icon
1350
Ball Corp
BALL
$17B
-19,064
Closed -$1.1M

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.